Best GLP-1 Weight Loss Programs 2026, Ranked

There is no single "best", it depends on the constraint that matters most to you. This page computes five separate verdicts (cheapest without insurance, cheapest month-to-month, cheapest on a 12-month plan, no membership fee, and best for higher doses) directly from our verified provider registry, each with a named provider, a real price, and that record’s own verification date.

As of October 21, 2026, the lowest verified all-in monthly price with no insurance dependency is Embody at $69/mo, medication included. See the full ranked list and how each program handles dose escalation →

As of October 21, 2026, the lowest verified all-in monthly price available with no 12-month or annual commitment is Embody at $69/mo. Programs on a 12-month or annual plan usually charge less per month but require the longer term, compare both before deciding. Compare every verified price and term on the full Price Index →

As of November 10, 2026, the lowest verified all-in monthly price on a 12-month (or annual) commitment plan is HealthRX at $97/mo. Read how each program bills the term before you commit to a year →

As of October 21, 2026, the lowest verified price with zero separate membership fee is Embody at $69/mo, that figure is the full recurring bill, not a teaser rate with medication billed on top. "No membership fee" is not the same claim as "cheapest overall." Compare the full ranked list and every program’s total cost →

Embody holds the same verified price at every dose, so its $69/mo entry rate is the same at the highest (maintenance) dose too, with no step-up as you titrate, verified October 21, 2026. Most GLP-1 programs charge more as your dose escalates; a flat-dose program avoids that step-up entirely. See every flat-dose program we track →

Because the underlying registry currently supports the same answer to both questions, today, our verified data shows the same provider is both the cheapest option with no insurance dependency and the cheapest option with no separate membership fee. Each verdict is computed independently from its own eligibility rule; we are not hiding a coincidence, and if either rule’s answer changes, the two verdicts will diverge automatically.

This page answers five specific, high-intent questions with one named winner each and routes you to the deeper comparison page for that constraint. The GLP-1 Price Index is the full sortable dataset behind every verdict here, every tracked program, every price, every verification date, in one table. See the full GLP-1 Price Index →

Every price shown carries its own verification date, checked against that provider’s own pricing page, never a page-wide "verified today" claim. A nightly automated audit separately re-reads provider sites and writes a correction only when the program’s exact wording is on the page, holding large or ambiguous changes for a person; see the freshness note below for exactly what that process does and does not claim. Read exactly how we verify prices →

No. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually FDA-approved finished products. Compounders describe them as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms (semaglutide sodium or acetate) it considers different active ingredients from the approved drug. See our full verification methodology →